Cardiotronic - In Business for Life
Cardiotronic was founded in March 2001 as a United States subsidiary to Osypka Medical. Osypka Medical, with facilities in La Jolla, California and Berlin, Germany, has been around for nearly 30 years in providing cutting-edge technology in cardiac rhythm management. Serving the Americas, Cardiotronic is committed to non-invasive cardiac the distribution of non-invasive cardiac monitors and cardiac rhythm management devices.
The Osypka brand is associated with the name of Peter Osypka, Ph.D., who achieved worldwide recognition for his contributions to cardiac pacing, radio-frequency ablation and electrophysiology, including more than 250 patents. Dr. Osypka is chairman of the board of Osypka AG Rheinfelden (Germany) and professor at the University of Applied Sciences in Offenburg (Germany).
Electrical Cardiometry™ (EC)
Cardiotronic was formed for the sole purpose of developing, designing, and marketing an accurate, cost-effective, and safe method of measuring hemodynamics and ultimately, improving patient outcomes.
In 2008, the ICON® and AESCULON®, non-invasive cardiac output monitors were FDA approved and US market released. Cardiotronic’s EC monitors provided the first, and only accurate bioimpedance based monitors FDA approved for measuring non-invasive hemodynamic parameters in ALL ranges of patients (neonates, pediatrics, and adults).
Cardiotronic’s Core Principles
- Always be passionate about the work you do
- Action with a vision is making a positive difference
- Follow through on your commitments and promises
- Your work is never done; there is always room for continual improvement
Mission
Cardiotronic is committed to providing a safe, cost-effective, and accurate measure of hemodynamics to improve patient outcomes and reduce hospital costs. Furthermore, it is Cardiotronic’s mission to collaborate with hospital staff and other medical technologies to find new avenues of use for cardiac output and other related hemodynamic parameters.
